Brief: Cellyan Biotechnology Says Selling Shareholders May Offer 12.5 Mln Class A Ordinary Shares
27/03/2026 19:33
March 27 (Reuters) - Cellyan Biotechnology Co Ltd HKPD.O: CELLYAN BIOTECHNOLOGY CO LTD - SELLING SHAREHOLDERS MAY OFFER UP TO 12.5 MILLION CLASS A ORDINARY SHARES FROM TIME TO TIME - SEC FILING Source text: [ID:n0001213900-26-035450] Further company coverage: HKPD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellyan Biotechnology
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Cellyan Biotechnology Announces A 1-For-20 Reverse Stock Split
Brief: Cellyan Biotechnology Says Selling Shareholders May Offer 12.5 Mln Class A Ordinary Shares
Brief: Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results For The Six Months Ended September 30, 2024